Time trend of multiple myeloma and associated secondary primary malignancies in Asian patients: a Taiwan population-based study.

Studies involving second malignancies in patients with multiple myeloma are limited for the Asian population. Using data from population-based insurance claims, we assessed the risk of developing secondary malignancies after multiple myeloma, in particular hematologic malignancies. A retrospective c...

Full description

Bibliographic Details
Main Authors: Huey-En Tzeng, Cheng-Li Lin, Chun-Hao Tsai, Chih-Hsin Tang, Wen-Li Hwang, Ya-Wen Cheng, Fung-Chang Sung, Chi-Jung Chung
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3699496?pdf=render
_version_ 1819080903297597440
author Huey-En Tzeng
Cheng-Li Lin
Chun-Hao Tsai
Chih-Hsin Tang
Wen-Li Hwang
Ya-Wen Cheng
Fung-Chang Sung
Chi-Jung Chung
author_facet Huey-En Tzeng
Cheng-Li Lin
Chun-Hao Tsai
Chih-Hsin Tang
Wen-Li Hwang
Ya-Wen Cheng
Fung-Chang Sung
Chi-Jung Chung
author_sort Huey-En Tzeng
collection DOAJ
description Studies involving second malignancies in patients with multiple myeloma are limited for the Asian population. Using data from population-based insurance claims, we assessed the risk of developing secondary malignancies after multiple myeloma, in particular hematologic malignancies. A retrospective cohort study was conducted in 3970 patients with newly diagnosed multiple myeloma from the registry of catastrophic illnesses between 1997 and 2009. A total of 15880 subjects without multiple myeloma were randomly selected as comparisons from the insured population, frequency-matched based on gender, age, and the date of diagnosis. The incidence of secondary malignancies was ascertained through cross-referencing with the National Cancer Registry System. The Cox proportional hazards model was used for analyses. The incidence of multiple myeloma in the insured population increased annually. The overall incidence of secondary malignancy was lower in the multiple myeloma cohort than in the comparison cohort (93.6 vs. 104.5 per 10,000 person-years, IRR = 0.90, 95% CI = 0.78-1.04). The incidence of hematologic malignancies was 11-fold greater for multiple myeloma patients (47.2 vs. 4.09 per 10,000 person-years) with an adjusted HR of 13.0 (95% CI = 7.79-21.6) compared with the comparison cohort. The relative risk of secondary malignancy was also strong for myeloid leukemia (21.2 vs. 1.36 per 10,000 person-years). Gender- and age-specific analysis for secondary hematologic malignancies showed that males and patients with multiple myeloma <60 years of age had a higher risk of secondary malignancy than females and patients with multiple myeloma >60 years of age. In conclusion, patients with multiple myeloma, especially younger patients, are at a high risk of hematologic malignancies.
first_indexed 2024-12-21T19:52:16Z
format Article
id doaj.art-f439cb2160924f6594f4e3a2deca66cd
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-21T19:52:16Z
publishDate 2013-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-f439cb2160924f6594f4e3a2deca66cd2022-12-21T18:52:11ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-0187e6804110.1371/journal.pone.0068041Time trend of multiple myeloma and associated secondary primary malignancies in Asian patients: a Taiwan population-based study.Huey-En TzengCheng-Li LinChun-Hao TsaiChih-Hsin TangWen-Li HwangYa-Wen ChengFung-Chang SungChi-Jung ChungStudies involving second malignancies in patients with multiple myeloma are limited for the Asian population. Using data from population-based insurance claims, we assessed the risk of developing secondary malignancies after multiple myeloma, in particular hematologic malignancies. A retrospective cohort study was conducted in 3970 patients with newly diagnosed multiple myeloma from the registry of catastrophic illnesses between 1997 and 2009. A total of 15880 subjects without multiple myeloma were randomly selected as comparisons from the insured population, frequency-matched based on gender, age, and the date of diagnosis. The incidence of secondary malignancies was ascertained through cross-referencing with the National Cancer Registry System. The Cox proportional hazards model was used for analyses. The incidence of multiple myeloma in the insured population increased annually. The overall incidence of secondary malignancy was lower in the multiple myeloma cohort than in the comparison cohort (93.6 vs. 104.5 per 10,000 person-years, IRR = 0.90, 95% CI = 0.78-1.04). The incidence of hematologic malignancies was 11-fold greater for multiple myeloma patients (47.2 vs. 4.09 per 10,000 person-years) with an adjusted HR of 13.0 (95% CI = 7.79-21.6) compared with the comparison cohort. The relative risk of secondary malignancy was also strong for myeloid leukemia (21.2 vs. 1.36 per 10,000 person-years). Gender- and age-specific analysis for secondary hematologic malignancies showed that males and patients with multiple myeloma <60 years of age had a higher risk of secondary malignancy than females and patients with multiple myeloma >60 years of age. In conclusion, patients with multiple myeloma, especially younger patients, are at a high risk of hematologic malignancies.http://europepmc.org/articles/PMC3699496?pdf=render
spellingShingle Huey-En Tzeng
Cheng-Li Lin
Chun-Hao Tsai
Chih-Hsin Tang
Wen-Li Hwang
Ya-Wen Cheng
Fung-Chang Sung
Chi-Jung Chung
Time trend of multiple myeloma and associated secondary primary malignancies in Asian patients: a Taiwan population-based study.
PLoS ONE
title Time trend of multiple myeloma and associated secondary primary malignancies in Asian patients: a Taiwan population-based study.
title_full Time trend of multiple myeloma and associated secondary primary malignancies in Asian patients: a Taiwan population-based study.
title_fullStr Time trend of multiple myeloma and associated secondary primary malignancies in Asian patients: a Taiwan population-based study.
title_full_unstemmed Time trend of multiple myeloma and associated secondary primary malignancies in Asian patients: a Taiwan population-based study.
title_short Time trend of multiple myeloma and associated secondary primary malignancies in Asian patients: a Taiwan population-based study.
title_sort time trend of multiple myeloma and associated secondary primary malignancies in asian patients a taiwan population based study
url http://europepmc.org/articles/PMC3699496?pdf=render
work_keys_str_mv AT hueyentzeng timetrendofmultiplemyelomaandassociatedsecondaryprimarymalignanciesinasianpatientsataiwanpopulationbasedstudy
AT chenglilin timetrendofmultiplemyelomaandassociatedsecondaryprimarymalignanciesinasianpatientsataiwanpopulationbasedstudy
AT chunhaotsai timetrendofmultiplemyelomaandassociatedsecondaryprimarymalignanciesinasianpatientsataiwanpopulationbasedstudy
AT chihhsintang timetrendofmultiplemyelomaandassociatedsecondaryprimarymalignanciesinasianpatientsataiwanpopulationbasedstudy
AT wenlihwang timetrendofmultiplemyelomaandassociatedsecondaryprimarymalignanciesinasianpatientsataiwanpopulationbasedstudy
AT yawencheng timetrendofmultiplemyelomaandassociatedsecondaryprimarymalignanciesinasianpatientsataiwanpopulationbasedstudy
AT fungchangsung timetrendofmultiplemyelomaandassociatedsecondaryprimarymalignanciesinasianpatientsataiwanpopulationbasedstudy
AT chijungchung timetrendofmultiplemyelomaandassociatedsecondaryprimarymalignanciesinasianpatientsataiwanpopulationbasedstudy